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Neurons and glia in the vertebrate central nervous
system arise in temporally distinct, albeit overlapping,
phases. Neurons are generated first followed by astro-
cytes and oligodendrocytes from common progenitor
cells. Increasing evidence indicates that axon-derived
signals spatiotemporally modulate oligodendrocyte
maturation and myelin formation. Our previous obser-
vations demonstrate that F3/contactin is a functional
ligand of Notch during oligodendrocyte maturation, re-
vealing the existence of another group of Notch ligands.
Here, we establish that NB-3, a member of the F3/con-
tactin family, acts as a novel Notch ligand to participate
in oligodendrocyte generation. NB-3 triggers nuclear
translocation of the Notch intracellular domain and pro-
motes oligodendrogliogenesis from progenitor cells and
differentiation of oligodendrocyte precursor cells via
Deltex1. In primary oligodendrocytes, NB-3 increases
myelin-associated glycoprotein transcripts. Thus, the
NB-3/Notch signaling pathway may prove to be a molec-
ular handle to treat demyelinating diseases.
Neural progenitor cells (NPCs)1 are self-renewing multipo-
tent cells that can give rise to all types of neural cells, namely
neurons, oligodendrocytes (OLs), and astrocytes. Increasing
evidence suggests that this fate commitment of NPCs requires
molecular cues provided by extracellular molecules and intrin-
sic signaling involving various transcription factors (1, 2). Our
recent study (3) has demonstrated that the F3/Notch signaling
pathway via Deltex1 (DTX1) promotes oligodendrocyte precur-
sor cell (OPC) differentiation into oligodendrocytes (OLs) and
up-regulates myelin-associated glycoprotein (MAG) expression
in both primary OLs and OLN-93 cells, an OL cell line. F3/
contactin is a glycosylphosphatidylinositol-anchored neural
cell adhesion molecule of the immunoglobulin superfamily (4,
5). However, the extracellular molecules involved in the pro-
gression from NPCs to OLs have been defined poorly.
The Notch signaling pathway mediates gliogenesis from
NPCs from embryonic day (E) 17 to 18 (6). Notch1 is a trans-
membrane molecule characterized by a novel signaling para-
digm, regulated intramembrane proteolysis (RIP) (7). Upon
activation by the typical ligands, Delta, Serrate/Jagged, and
Lag2 (DSL), Notch undergoes two programmed proteolytic
cleavages and releases the intracellular domain (NICD) into
the nucleus where together with transcription factors CSL/
RBP-J and DTX1 NICD modulates the expression of different
target genes, such as Hes (8). Notably, NB-3, a close homologue
of F3/contactin (9, 10), is expressed from E17 onwards with an
abrupt increase in the postnatal period and reaches the peak
between postnatal day 7 (P7) and P21, which corresponds to
the time frame for oligodendrogliogenesis from progenitor cells
and OL maturation. In the present study, we demonstrate that
NB-3 is a neuronal molecule and activates the Notch signaling
pathway to direct OL generation from NPCs and OPCs via
DTX1.
EXPERIMENTAL PROCEDURES
Antibodies—Polyclonal GFAP (DAKO), Notch1 (kind gifts from Dr.
U. Lendahl), NICD (20), F3 (11), and MAG (3) antibodies, monoclonal
Notch1 epidermal growth factor (EGF) repeats (Neomarker), c-myc
(9E10), HA probe (Santa Cruz Biotechnology), FLAG, -tubulin, neu-
rofilament 200, CNPase, MAP2 (2a2b)(Sigma), V5 epitope (Invitro-
gen), galactocerebroside, glial fibrillary acidic protein (GFAP), and
CNPase (Chemicon) antibodies were used. NB-3 antibodies were gen-
erated by immunizing rabbits for antiserum and immunizing BALB/c
mice for the monoclonal antibody (12) with recombinant protein encod-
ing rat NB-3 Ig domains I-II (amino acids 30–227) expressed in Esch-
erichia coli.
Western Blot Analysis of Developmental Expression Patterns—The
striatum, hippocampus, cerebellum, spinal cord, and brain stem were
dissected from embryos at E17 or neonates between P0 and P21 of
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Wistar rats. The specimens were homogenized in 9 volumes of reducing
sample buffer and boiled for 5 min. Each 10-l aliquot of the homoge-
nates was subjected to a Western blot. Detection was carried out with
ECL Western blotting System (Amersham Biosciences).
Cell Culture—Neurons, OLs, and astrocytes of E17 Wistar rats were
isolated and cultured according to Itoh’s methods (13). OLs of P5–7
Wistar rat cerebella were obtained by Percoll gradient centrifugation
(14), and OPCs were purified from P5–7 Wistar rat optic nerves (15).
Culture of Neural Progenitor Cells—Murine neural progenitor cells
were isolated from striatum, hippocampus, cerebellum, and the spinal
cord of 14-day-old BALB/c mouse embryos (IFFA Credo, L’Arbresle,
France) and cultured in Dulbecco’s modified Eagle’s medium/F12 (1:1)
with N2 supplement and EGF (20 ng/ml) (Invitrogen) (16). Cells from
passages 6–15 were used to induce differentiation. The spheres were
dissociated mechanically into single cells and treated with NB-3 (12.5
nM) or Jagged1 (50 nM) in culture medium without growth factor for
24 h. The cells were then plated onto poly-L-lysine-coated coverslips
(Nunc) in 4-well dishes at a density of 3104/well in growth factor-free
culture medium with 1% fetal calf serum.
Immunocytochemistry—This was performed mainly as described (3).
For detection of primary neurofilament 200, GFAP, and galactocerebro-
side antibodies, Alexa Fluor 488-conjugated anti-mouse IgG or Alexa
Fluor 546-conjugated anti-rabbit IgG (1:1500; Molecular Probes) were
used. NPCs, OPCs, and OLN were first transfected with plasmid caN1,
DTX1-D1, DTX1-D2, dominant-negative (dn)-N1 and pcDNA4/LacZ-V5
(Invitrogen) using LipofectAMINE 2000 (Invitrogen). The NPCs were
treated with or without NB-3 in serum-free culture medium without
growth factor for 24 h, and then cells were allowed to differentiate on
13-mm coverslips in 1% fetal calf serum medium for 7 days. The OPC
and OLN were treated with NB-3 for 48 h. Cells were fixed with 4%
paraformaldehyde and blocked with 1% bovine serum albumin (BSA).
Cells were then incubated with primary antibodies in 0.2% BSA for 1 h
followed by Cy3- or Cy2-labeled secondary antibody (Amersham Bio-
sciences). After mounting in fluorescent mounting medium (DAKO),
cells were visualized with a Leica DM RXA2 fluorescent microscope.
The photos were taken using the same optical parameters to ensure the
comparable luminosity. At least 10 different viewing fields from three
independent experiments were used to calculate the percentage of cells
showing NICD translocation or differentiation. In the case of -secre-
tase inhibitor (Sigma) treatment, OLN cells were incubated with a 200
M concentration of this inhibitor for 2 h prior to NB-3 treatment.
Two-hundred cells from at least three independent experiments were
quantified for fluorescence intensities by Adobe PhotoshopTM (17). The
raw data were analyzed by Student’s t test with p  0.05 and p  0.01
being considered a significant or highly significant difference,
respectively.
Cell Adhesion Assay—The cell adhesion assay was performed as
described (4). Briefly, 35-mm tissue culture Petri dishes (Becton Dick-
inson) were coated with methanol-solubilized nitrocellulose and then
proteins (12 M) for 2 h at 37 °C in a humidified atmosphere. Subse-
quently, the dishes were washed and blocked overnight with 2% heat-
inactivated fatty acid-free BSA (Sigma). After rinsing the dishes, the
cells were plated in 2 ml of chemically defined medium at a density of
1.5  106cells/ml. At 0.5 h, the cells were gently washed and fixed with
2.5% glutaldehyde. Blockage of adhesion was carried out using anti-F3
(1:100), anti-NB-3 (1:100), and anti-Notch1 (1:200) antibodies. Cells
adhering to the various spots were photographed and counted. The
results were analyzed with a Newman-Keuls test with p 0.05 and p
0.01 being considered a significant or highly significant difference,
respectively.
Production of Recombinant NB-3-Fc Proteins—The signal sequence
of the glycosylphosphatidylinositol anchor was substituted with human
IgG Fc followed by a termination codon. The cDNA thus manipulated
was inserted into pREP4 between the Hind III and BamHI sites and
transfected into HEK293 cells. NB-3-Fc was purified from the condi-
tioned medium using protein A-agarose (Roche Applied Science).
The production of Notch1 GST fusion proteins has been described
previously (3). Four sequential equal-sized fragments (EGF repeats
1–13), N1.2 (EGF repeats 11–24), N1.3 (EGF repeats 22–34), and N1.4
(EGF repeats 32–36, LNR repeats), were produced in E. coli.
Co-immunoprecipitation and GST Pull-down Assay—These assays
were carried out as described (3). In brief, rat brain membrane samples
were incubated overnight at 4 °C with protein A-agarose beads (coupled
with NB-3-Fc or indicated antibodies, or glutathione-agarose beads)
bound to GST-N1.1, N1.2, N1.3, or N1.4. Captured proteins were sep-
arated and detected in SDS-PAGE and Western blot.
Flow Cytometric Analysis—After 7 days in vitro culture, the differ-
entiated NPCs were trypsinized, washed with phosphate-buffered sa-
line, and treated with FACSPerm (Becton Dickinson). Cells were
stained with antibody MAP2 (2a2b), GFAP, CNPase, and fluorescein
isothiocyanate-conjugated anti-mouse IgG1 and anti-rabbit IgG, then
analyzed by flow cytometer (FACScalibur, BD Biosciences) with Cell
Quest software (BD Biosciences). Raw data were analyzed and com-
pared with Student’s t test.
Transient and Stable Transfection—Cells were transfected with var-
ious plasmids using LipofectAMINE 2000. Stable transfectants were
selected with 400 g/ml G418 (Sigma) and identified by Western blot
and immunocytochemistry.
Luciferase Reporter Assay—The luciferase reporter assay was per-
formed as described (3). NPCs (1.5  105/well) in 12-well dishes were
used for Hes1 luciferase reporter assays. Cells were transiently trans-
fected using LipofectAMINE and LipofectAMINE Plus reagents. Each
well received 0.2 g of pGVB/Hes1 luciferase reporter plasmid together
with various expression plasmids (0.2 g of caN1, 0.6 g of dnN1,
DTX1-D1-HA, and DTX1-D2-FLAG). For dnN1, cells were then treated
with 50 nM Jagged1. The -galactosidase expression plasmid pCMV/-
Gal was included to monitor the transfection efficiency. Cells were lysed
at 24-h post-transfection and assayed using the Steady-Glo luciferase
assay kit (Promega). The raw data from at least four independent
experiments were used to determine the relative reporter activity.
Real Time PCR Analysis—Real time PCR analysis was performed as
described (3). Total RNA from primary OLs was extracted using the
Qiagen RNeasy kit and treated with RNase-free DNaseI (Invitrogen).
Samples were used for reverse transcription with random hexamer
primers using TaqMan RT kit (Applied Biosystems). Glyceraldehyde-
3-phosphate dehydrogenase was used as an internal control. Real time
PCR was performed using the TaqMan system on an ABI PRISM 7700
sequence detection system. The primers and TaqMan probes were de-
signed using Primer Express Software (ABI), and sequences are avail-
able upon request. The raw data from at least four independent exper-
iments were used to determine the relative expression levels of each
transcript by employing the comparative CT method (34).
FIG. 1. Characterization of NB-3 expression. A, NB-3 is ex-
pressed from E17. Striatum (a), hippocampus (b), cerebellum (c), brain
stem (d), and spinal cord (e) from rats with indicated ages were homog-
enized and subjected to immunoblot for NB-3, F3, MAG and Notch1. B,
NB-3 is expressed by neurons. Purified neurons (a), OLs (b), and astro-
cytes (c) from E17 cerebella were cultured and double-stained for NB-3
and respective markers: neurofilament 200 (NF200) for neuron, galac-
tocerebroside (GAL-C) for oligodendrocyte, and GFAP for astrocyte.
Scale bar in c  30 m.
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RESULTS
NB-3 Expression Parallels OL Development—To better un-
derstand the potential role of both NB-3 and Notch in the
context of oligodendrogliogenesis from progenitor cells, we in-
vestigated the developmental expression patterns of NB-3 and
Notch1. A Western blot of different rat brain parts, striatum,
hippocampus, cerebellum, the brain stem, and spinal cord,
showed that both NB-3 and Notch1 were present at E17, and in
hippocampus, cerebellum, and the brain stem, NB-3 showed an
abrupt increase after birth and reached a maximum level be-
tween P0 and P21, which corresponds to the time frame of
oligodendrogliogenesis (Fig. 1A). On the other hand, the ex-
pression of F3 is generally later than NB-3, which was most
obviously seen in the cerebellum and hippocampus. In the
striatum, cerebellum, and spinal cord, the F3 expression level
was apparently lower than NB-3 at comparable developmental
stages. As expected, MAG showed observable expression rather
late (from P14) except in the brain stem.
NB-3 Is a Neuronal Molecule—To determine the cell type(s)
that express NB-3, purified neurons, OLs, and astrocytes from
E17 rat cerebella were separately cultured and double-stained
for NB-3 and specific markers, neurofilament 200 for neurons
(Fig. 1B, a), galactocerebroside for OLs (Fig. 1B, b), and GFAP
for astrocytes (Fig. 1B, c). Only the neurons expressed NB-3.
NB-3 and Notch Are Binding Partners—F3 has been shown
to interact with Notch (3). We were interested in determining
whether NB-3 also bound to Notch. First, we studied the ex-
pression of Notch1 on NPCs by immunofluorescence. The pro-
genitor cells were isolated from embryonic day 14 BALB/c
mouse embryo striatum (16). These cells expressed the inter-
mediate filament protein nestin (Fig. 2A, a), a progenitor
marker, and Notch1 (Fig. 2A, b and c). Then NB-3-Fc fusion
protein coupled to protein A beads was used to precipitate
potential binding partners of NB-3 from progenitor cell mem-
brane extracts. The precipitate was positively blotted with
Notch1 antibody (Fig. 2B, a). Further, we immunoprecipitated
P0 and adult (not shown) rat brain membrane extracts using
NB-3 antibody and blotted the precipitates with Notch1 anti-
body and vice versa. Western blot showed reciprocal co-immu-
noprecipitation of NB-3 and Notch1 (Fig. 2B, b and c) suggest-
ing a potential interaction between NB-3 and Notch1.
To confirm the NB-3/Notch interaction, OLN-93 (OLN) cells,
a permanent cell line resembling maturing OLs (18) were used
in cell adhesion assays as described (3, 4). Immunocytochem-
istry showed that OLN cells expressed Notch1 (Fig. 2C, a).
Cells adhered to the coated NB-3-Fc (NB-3) substrate (Fig. 2C,
b) but not to CHL1-Fc, another neural cell adhesion molecule
(19) (Fig. 2C, g). The adhesion was blocked by preincubation
with NB-3 or Notch1 antibodies, but not with F3 antibody or
preimmune serum (Fig. 2C, e and f). Interestingly, upon con-
tact with NB-3, cells enlarged rapidly to form an expansive
cytoplasmic sheet (Fig. 2C, b) suggesting that NB-3 might
signal to OLN cells to induce a morphological change. In addi-
tion, murine Notch1-transfected HeLa cells also adhered to
NB-3, but mock-transfected HeLa cells did not. Adhesion was
reversed by the addition of NB-3 or Notch1 antibodies but not
by preimmune serum (Fig. 2C, h).
To map the binding site(s) on Notch1, four subcloned sequen-
tial equal-sized portions of the mouse Notch1 extracellular
domain, labeled as N1.1, N1.2, N1.3, and N1.4 (3), were used in
a GST pull-down assay from rat brain lysates. Immunoblotting
showed that NB-3 associated only with N1.3, a region contain-
FIG. 2. NB-3 is a binding partner of
Notch1. A, NPCs express Notch1. NPCs
were double-stained for precursor marker
nestin (a) and Notch1 (b); c is the merged
picture. Scale bar in c  60 m for a–c. B,
NB-3 binds to Notch1. NPCs samples
were precipitated with protein A beads
coupled with NB-3-Fc (a), P0 rat brain
samples were immunoprecipitated using
-NB-3 or -Notch1, and the precipitates
were blotted as indicated (b and c).C, cell
adhesion assay. OLN cells were labeled
with -Notch1 (a). OLN cells were seeded
on NB-3 substrate (b) or in the presence of
-Notch1 (c), -NB-3 (d), -F3 (e), or pre-
immune serum (f). g, quantification of
OLN cell adhesion on the NB-3 substrate
and the effects of blocking antibodies. #,
p 0.05 compared with CHL1; *, p 0.05
compared with preimmune serum. Scale
bar in f 8 m for a–f. h, quantification of
mouse N1-transfected HeLa cell adhesion
on NB-3 substrate and the effects of anti-
body blockade. Mouse N1-transfected
HeLa cells or mock-transfected HeLa cells
were plated on NB-3 or in the presence of
-NB-3, -Notch1, or pre-immune serum.
*, p  0.05 compared with mock-trans-
fected cells; #, p  0.05 compared with
preimmune serum. i, NB-3 binds to a spe-
cific region on Notch1. The GST-Notch1
extracellular fragments (N1.1, N1.2,
N1.3, and N1.4) or GST alone were used
in a GST pull-down assay with rat brain
lysate. The precipitates and brain lysates
were probed for NB-3. j, quantification of
adherent NB-3- and mock-transfected
Chinese hamster ovary (CHO) cells to the
four Notch1 GST fusion fragments. *, p 
0.05 compared with GST.
NB-3 Promotes Oligodendroglial Differentiation25860
 at UQ Library on September 5, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
FIG. 3. NB-3 is a functional ligand of
Notch1. A, NB-3 induces NICD nuclear
translocation. NPCs were individually
treated with NB-3 (12.5 nM) (a–d),
Jagged1 (50 nM) (e–h), or BSA (i–l) for
24 h then fixed and triple-stained for nes-
tin (green), NICD (red), and DAPI (blue)
to locate NICD. Scale bar in l  25 m for
a–l. B, NB-3/Notch interaction induces
NICD nuclear translocation in OLN cells.
Mouse Notch1-transfected OLN cells
treated with NB-3 (a), Jagged1 (b), and
BSA (c) were immunostained for NICD.
Some cells were treated with EGF anti-
body (d) or -secretase inhibitor (e) before
NB-3 stimulation. OLN cells were also
transfected with V1744K-myc (f and h) or
V1744L-myc (g and i), treated with NB-3
(f and g) or Jagged1 (h and i), and immu-
nostained with c-myc antibody to locate
NICD. Scale bar in a  20 m for a–i. j,
after NB-3 or Jagged1 treatment, -c-myc
precipitates from mouse Notch1-myc-,
V1744K-myc-, or V1744L-myc-trans-
fected OLN cells were immunoblotted by
-NICD (top panel) or -V1744 (bottom
panel).
FIG. 4. NB-3 promotes OL genera-
tion. NPCs were passaged into mitogen-
withdrawn culture medium that was sup-
plemented with NB-3 (A and D), BSA (B
and E), or Jagged1 (C and F). After 7 days
in vitro culture differentiation, the cells
were triple-stained for CNPase (A–C,
red), -tubulin (D and F, red), or GFAP (A
and F, green) and DAPI (A–F, blue). Other
NPCs were individually immunolabeled
with marker antibody and subjected to
flow cytometry. The percent of each type
of cell, OLs, neurons, and astrocytes, were
counted (G). Data are mean  S.D. * and
#, p  0.01 in Student’s t test, compared
with BSA. Scale bar in F 40 m for A–F.
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ing EGF repeats 22–34 (Fig. 2C, i). The specificity was con-
firmed by the observations that NB-3-transfected Chinese
hamster ovary cells plated upon the individual recombinant
fragments bound predominantly to N1.3 (Fig. 2C, j), whereas
mock-transfected Chinese hamster ovary cells did not bind.
Together, these results support the concept that NB-3 is a
binding partner of Notch1.
NB-3 Triggers Notch RIP at the S3 Site and Transports
NICD to the Nucleus—Notch activation by ligand binding is
characterized by NICD nuclear translocation (20). We studied
whether NICD nuclear translocation in progenitor cells could
occur in response to NB-3 stimulation. Merged triple staining
showed that NB-3 treatment of nestin-positive (green) progen-
itor cells resulted in NICD clustering (red) in the nucleus
visualized by 4,6-diamidino-2-phenylindole (DAPI) (blue) (Fig.
3A, a–d), which was similar to Jagged1 stimulation (Fig. 3A,
e–h). However, BSA failed to trigger this event (Fig. 3A, i–l). To
confirm this, we investigated whether NB-3 could activate
Notch in OLN cells. Cells were transfected with mouse Notch1-
myc encoding myc-tagged full-length mouse Notch1 and
treated with NB-3 (Fig. 3B, a) or Jagged1 (Fig. 3B, b). In both
cases NICD concentrated in the nucleus. BSA failed to affect
this (Fig. 3B, c). An antibody against EGF repeats on Notch1
prevented NB-3-induced NICD nuclear clustering (Fig. 3B, d).
These observations indicated that NB-3 interacts with Notch1
to effect typical NICD nuclear translocation.
To study the properties of NB-3-induced NICD release, OLN
cells were preincubated with -secretase inhibitor before expo-
sure to NB-3 (Fig. 3B, e) or Jagged1 (not shown). This inhibitor
specifically targets aspartyl protease. In both cases, nuclear
NICD clustering was abolished, indicating that NB-3-induced
NICD release involves -secretase. Moreover, cells transfected
with two S3 mutants, myc-tagged V1744K and V1744L, which
abolished S3 cleavage (20), successfully prevented NB-3-in-
duced (Fig. 3B, f and g) as well as Jagged1-induced (Fig. 3B, h
and i) NICD nuclear translocation. In the Western blot (Fig.
3B, j), c-myc antibody precipitates from either NB-3 or
Jagged1-treated V1744K-myc or V1744L-myc-transfected OLN
cells could only be blotted by the NICD antibody, which also
recognizes intact Notch1 (250 kDa) (upper panel) but not by
V1744 antibody, which only recognizes released NICD from the
S3 site. In contrast, mouse Notch-myc transfected OLN cells
generated NICD (120 kDa) that was blotted by V1744 anti-
body after NB-3 or Jagged1 treatment (Fig. 3B, j, bottom
panel). Together, these results demonstrated that NB-3 in-
duced -secretase-dependent Notch1 RIP at the S3 site.
NB-3 Promotes Oligodendrogliogenesis—Given the parallel
expression of both NB-3 and Notch1 during development, we
explored whether the NB-3/Notch interaction was involved in
oligodendrogliogenesis from progenitor cells. To do this, embry-
onic neural progenitors were allowed to differentiate for 7 days
in the absence of mitogen and in the presence of serum and
NB-3 (Fig. 4, A and D), BSA (Fig. 4, B and E), or Jagged1 (Fig.
4, C and F), respectively. The cells, identified by DAPI (Fig. 4,
A–F, blue), were immunostained for OL marker CNPase (Fig.
4, A–C, red), neuronal marker -tubulin (Fig. 4, D–F, red), and
astrocyte marker GFAP (Fig. 4, A–F, green). The results
TABLE I
NB-3 induces oligodendrogliogenesis from neural progenitor cells in
different parts of the central nervous system
For every cell line treated with individual proteins, CNPase-positive
oligodendrocytes in each of the 50 fields taken from 10 coverslips (5
fields/coverslip) were counted and represented as the mean percent-
age S.D. of the total cells visualized by DAPI labeling in each field. At
least 40–60 cells were counted in each field.
NB-3 BSA Jagged1
% % %
Fetal striatum 45.1  16.3a 22.2  17.5 5.6  1.8a
Fetal hippocampus 37.5  12.3a 21.9  12.7 8.7  6.3a
Fetal cerebellum 36.5  8.6a 17.3  8.7 6.9  5.5a
Fetal spinal cord 39.1  11.3a 19.3  13.5 8.6  7.6a
a p  0.01 in Student’s t test, compared with BSA treatment.
FIG. 5. NB-3/Notch interaction promotes oligodendrogliogenesis from NPCs via DTX1. NPCs were transfected with dn-N1 (A and F),
DTX1-D2 (B and G) followed by NB-3 (12.5 nM) treatment, or caN1 transfection (C and H). As a control vector, pcDNA4/LacZ-V5 was introduced
into NPCs, which were then treated with NB-3 (D and I) or BSA (E and J). Cells were double-stained afterward for appropriate tags and CNPase
(A–E) or GFAP (F–J). K, schematic structure of DTX1 and its two deletion mutants. Numbers 1, 2, and 3 correspond to N-terminal, praline-rich
region, and Ring-H2 finger motif, respectively. The validity of the constructs utilized here was confirmed in Hes1 luciferase reporter assays (L).
Bars are mean  S.D. *, p  0.01 compared with Hes1 single transfection in Student’s t test. The percents of transfected cells that were positive
for CNPase or GFAP were counted (M). Data are mean  S.D. *, p  0.01 compared with BSA in Student’s t test. Scale bar in J  40 m.
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showed that, distinct from BSA and Jagged1, NB-3 promoted
OL generation from progenitor cells. On the other hand, com-
pared with BSA, NB-3 had little impact on neurogenesis,
whereas Jagged1 inhibited neurogenesis, which is consistent
with the function of the typical ligands of Notch (21). Flow
cytometry confirmed these observations in that NB-3 induced a
2-fold increase in OL generated compared with BSA treatment,
whereas Jagged1 inhibited OL development (Fig. 4G). Further-
more, by using other NPCs isolated from different parts of the
brain, we obtained similar results in immunofluorescence as-
says (Table I). For example, in NPCs from the fetal striatum,
NB-3 treatment results in 45.1  16.3% CNPase-positive OLs,
which is significantly higher than BSA (22.2  17.5%) or
Jagged1 (5.6  1.8%) treatment. For the other three cell lines
from the fetal hippocampus (37.5  12.3%), cerebellum (36.5 
8.6%), and spinal cord (39.1  11.3), the results are quite
consistent with the notion that NB-3 treatment specifically
favors OL generation from NPCs.
NB-3/Notch Signaling via DTX1 Is Involved in Oligodendro-
gliogenesis—To confirm the involvement of Notch1 in this
event, the embryonic progenitor cells from the striatum were
transfected with a V5-tagged dominant-negative Notch1 (dn-
N1) (22) that lacks the intracellular domain but can still bind to
extracellular ligand. Hes1 luciferase reporter assay showed
that dn-N1 failed to respond to Jagged1 treatment to activate
Hes1, compared with Jagged1 treatment of normal NPCs (Fig.
5L). Double labeling for V5 and CNPase or GFAP showed that
the dysfunction of Notch1 by dn-N1 abolished NB-3-promoted
oligodendrogenesis, while favoring astrocyte formation (Fig. 5,
A, F, and M). To further investigate whether DTX1 participates
in NB-3-induced OL formation, cells were transfected with
HA-tagged DTX1-D1 (23) and FLAG-tagged DTX1-D2 (24)
(Fig. 5, B and G). The Hes1 luciferase reporter assay confirmed
that DTX1 inhibited Hes1 activation by caN1, whereas
DTX1-D1 and DTX1-D2 restored Hes1 elevation by caN1 (Fig.
5L). After differentiation in the presence of NB-3, cells were
immunostained for FLAG and CNPase or GFAP. The results
showed that DTX1-D1- (not shown) and DTX1-D2-transfected
cells failed to differentiate into OL after NB-3 stimulation but
were directed to astrocytes (Fig. 5, B, G, and M). And consistent
with a previous study (25) the introduction of caN1 into pro-
genitor cells resulted in astrogliogenesis while inhibiting OL
generation (Fig. 5, C, H, and M). pcDNA4/LacZ-V5 was used as
a control vector, and the introduction of this vector into the
progenitor cells did not affect the effects of NB-3 (Fig. 5, D and
I) and BSA (Fig. 5, E and J) on oligodendrocyte generation and
astrogliogenesis. These observations indicate that NB-3 pro-
moted oligodendrogliogenesis via the Notch/DTX1 signaling
pathway.
NB-3 Promotes OPC Differentiation into OLs via Notch/
DTX1—To investigate whether the NB-3/Notch interaction is
involved in OL maturation, purified OPCs from P7 Wistar rat
optic nerve (Fig. 6A) were treated with BSA, NB-3, or Jagged1
for 2 days and then immunostained for Ng2 (red), a progenitor
marker, and CNPase (green), a young OL marker (Fig. 6, B–D).
Statistical counting showed that NB-3 promoted OPC differen-
tiation into CNPase-positive OLs (75%), compared with BSA
(50%) or Jagged1 (0%) treatment (Fig. 6J). To confirm the
involvement of Notch1/DTX1 signaling in NB-3-promoted OPC
differentiation, OPCs were transfected with dn-N1 (Fig. 6E) or
DTX1-D1 (Fig. 6F) and treated simultaneously with NB-3.
Double labeling for tags (green) and CNPase (red) showed that
introduction of either construct significantly blocked NB-3-
promoted OPC differentiation into OLs (Fig. 6J). And consist-
ent with a previous study (26), caN1-transfected OPCs re-
mained undifferentiated (Fig. 6, G and J). As a vector control,
pcDNA4/LacZ-V5 was introduced into OPCs but did not affect
either NB-3- or BSA-induced OPC differentiation progress (Fig.
FIG. 6. NB-3/Notch signaling pro-
motes OL maturation from OPCs. Pu-
rified Ng2-positive OPCs from P7 rat op-
tic nerve (A) were treated with BSA (B),
NB-3 (C), or Jagged1 (D) for 2 days and
double-labeled for Ng2 (red) and CNPase
(green). Other cells were transfected with
dn-N1 (E), DTX1-D1 followed by NB-3
stimulation (F), or caN1 alone (G). As a
vector control, OPCs were transfected
with pcDNA4/LacZ-V5 and treated with
NB-3 (H) or BSA (I). Cells were then im-
munostained for tags (green) and CNPase
(red). The percentage of CNPase-positive
cells was counted (J). Data are mean 
S.E. *, p  0.01, compared with BSA; #,
p  0.001, compared with BSA in Stu-
dent’s t test. B:,BSA; N, NB-3; J, Jagged1;
ca, caN1; dn, dnN1; D, DTX1-D1. Isolated
OLs from P5–P7 rat cerebella were
treated with BSA or NB-3 and subjected
to real time PCR analysis (K). The scale
bar in I  40 m.
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6, H, I, and J). In primary OLs, we analyzed the mRNA levels
of MAG, a hallmark of OL maturation, by real time PCR. The
analysis showed that NB-3 treatment increased MAG mRNA
24-fold compared with BSA treatment (Fig. 6K). These re-
sults indicated that NB-3/Notch is also involved in OPC
maturation.
DISCUSSION
We have shown that NB-3, a neuronal molecule, is a func-
tional ligand of Notch1. NB-3 activation of Notch releases
NICD at the S3 site via RIP and triggers the Notch/DTX1
signaling pathway, thus promoting oligodendrogliogenesis
from NPCs and OPCs and OL maturation by up-regulating
myelin-related proteins in young OLs (Fig. 7).
A recent study (27) shows that conditional ablation of Notch1
in OPCs results in the appearance of ectopic premature OLs
and subsequent apoptosis. Moreover, in multiple sclerosis, the
effort of remyelination is partly thwarted by the inflammation-
induced Jagged1 expression by astrocytes that surround OPCs
(28). These observations indicate that the spontaneous devel-
opment of OPCs could be disordered when Notch1 is absent or
inadequately activated by Jagged1, and other instructive path-
ways via Notch, besides the inhibitory Jagged1/Notch signaling
pathway, may contribute to correct OPC differentiation into
OLs. This notion is supported by our recent findings that the
F3/Notch signaling pathway promotes OL maturation (3) and
by the present study involving NB-3.
In the NB-3 null mice, the cerebellum-related motor coordi-
nation is impaired (29), and in F3/contactin mutants, severe
ataxic phenotype consistencies with defects in the cerebellum
(30) are present, indicating that both NB-3 and F3/contactin
contribute to cerebellar development. Notably, in the striatum,
hippocampus, cerebellum and spinal cord, the NB-3 protein
level was higher than F3 from embryonic day 17 to postnatal
day 14. And observable F3 expression generally started from
around birth or even later (Fig. 1A). Thus NB-3 appears to
function under physiological conditions from an earlier stage
than F3 does, especially in embryonic days and may play a
predominant specific role in some parts of the brain. Thus
NB-3/Notch signaling may function coordinately with F3/Notch
either spatially (different regions of the brain) or temporally
(embryonic or postnatal stage). Of course, future work is
needed to justify the differential usage of NB-3/Notch and
F3/Notch in vivo.
Increasing evidence indicates that OL differentiation is me-
diated by neuron derived signals, such as DSL and F3/contac-
tin (3, 4, 31). In a similar fashion to F3/contactin (3), NB-3
binds to N1.3, a region containing EGF repeats 22–34, whereas
DSL binds to EGF repeats 11–12. As a result of the binding,
NICD is released and translocated into the nucleus, a well
established feature of Notch activation. The blockage of this
phenomenon by the EGF antibody confirms that Notch is
cleaved by NB-3 binding. This event can also be prevented by
-secretase inhibitor, implying the involvement of presenilin-
dependent -secretase in NB-3/Notch interaction. Further-
more, NB-3-induced NICD production is abolished in two S3
mutants, V1744K and V1744L, indicating that NB-3 binding
triggers RIP at the typical S3 site. In summary, these obser-
vations have demonstrated that NB-3, a F3/contactin homo-
logue, and Notch are functional binding partners.
NPCs possess the capability to generate all types of neural
cells when given the proper molecular cues (2). One mechanism
that is involved in fate selection is the lateral inhibition, exem-
plified by the typical Notch signaling (32). Cells expressing
classical ligands DSL signal to apposing Notch-expressing cells
to suppress the differentiation of these cells. Our recent finding
that F3/contactin acts as a functional Notch ligand to promote
OL generation from OPCs and OL maturation suggests the
multiple roles that Notch may play during OL development (3).
However, the exact scenario from NPCs to OLs remains ob-
scure. Here, we have demonstrated that NB-3, as a neuronal
cue, promotes OLs differentiation from both NPCs and OPC.
Blockage of the NB-3-induced oligodendrogenesis by DTX1-D1
and DTX1-D2 indicates that one Notch signaling component,
DTX1, participates in NB-3/Notch signaling pathway. Thus,
NB-3 may activate the Notch receptor and release NICD, which
then interacts with and recruits transcription factors, such as
DTX1, other than the typical factor RBP-J. This process may
start even earlier than the OPC stage; in other words, it may
start from progenitor cell stage. To support this notion, we have
demonstrated that NB-3 and Notch1 are distributed in the
striatum, hippocampus, cerebellum, brain stem, and spinal
cord from E17 suggesting that NB-3/Notch interaction is ex-
pected to occur widely in the central nervous system
spatiotemporally.
Multiple sclerosis is a chronic demyelinating disease of the
central nervous system. Transplantation of NPCs is a promis-
ing treatment for such diseases (28, 33). It will be of signifi-
cance to establish a reliable method for inducing the selective
differentiation of appropriate donor progenitor cells to OPCs or
OLs. Thus, this study involving NB-3/Notch interaction is of
clinical significance, because it is desirable that one be able to
preferentially activate NB-3/Notch signaling in endogenous or
exogenous NPCs to treat multiple sclerosis.
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